Company
TriSalus Life Sciences, Inc. (TLSI)
Standardized SEC financial data for TriSalus Life Sciences, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001826667 · NASDAQ · Surgical & Medical Instruments & Apparatus.
Gross margin
84.6%
Operating margin
-59.7%
Net margin
-86.9%
Revenue growth (YoY)
53.4%
Return on equity
115.8%
Free cash flow
-$18.9M
Debt / equity
-0.98×
Current ratio
2.80×
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | — | $12.4M | $18.5M | $29.4M | $45.2M |
| Cost of revenue | — | $2.3M |
Balance sheet
| USD | FY2021 | FY2022 | FY2023 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $30.3M | $9.7M | — | $12.1M | $8.9M | $20.8M |
| Inventory |
Cash flow
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Operating cash flow | -$1.7M | -$32.3M | -$50.6M | -$40.8M | -$18.0M |
| Capital expenditures | — | $655K |
Get TLSI data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/TLSI/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/TLSI/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"